ZA91614B - Agent for use in the prevention,control or reversal of hypertension - Google Patents

Agent for use in the prevention,control or reversal of hypertension

Info

Publication number
ZA91614B
ZA91614B ZA91614A ZA91614A ZA91614B ZA 91614 B ZA91614 B ZA 91614B ZA 91614 A ZA91614 A ZA 91614A ZA 91614 A ZA91614 A ZA 91614A ZA 91614 B ZA91614 B ZA 91614B
Authority
ZA
South Africa
Prior art keywords
hypertension
reversal
prevention
agent
control
Prior art date
Application number
ZA91614A
Inventor
Joseph Gerard Masterson
Gerard Masterson Joseph
Original Assignee
Elan Corp Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Corp Plc filed Critical Elan Corp Plc
Publication of ZA91614B publication Critical patent/ZA91614B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
ZA91614A 1990-01-29 1991-01-28 Agent for use in the prevention,control or reversal of hypertension ZA91614B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IE030690A IE900306A1 (en) 1990-01-29 1990-01-29 Agent for use in the prevention, control or reversal of¹hypertension

Publications (1)

Publication Number Publication Date
ZA91614B true ZA91614B (en) 1991-10-30

Family

ID=11010198

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA91614A ZA91614B (en) 1990-01-29 1991-01-28 Agent for use in the prevention,control or reversal of hypertension

Country Status (3)

Country Link
GB (1) GB2240472A (en)
IE (1) IE900306A1 (en)
ZA (1) ZA91614B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE193447T1 (en) * 1992-02-24 2000-06-15 Univ East Carolina METHOD FOR INHIBITING CARCINOGENESIS BY TREATING WITH DEHYDROEPIANDROSTERONE AND ITS ANALOGUES
US7893044B2 (en) 1995-02-24 2011-02-22 Epigenesis Pharmaceutical, Inc. Composition and method for altering levels of or sensitivity to adenosine with analogs of dehydroepiandrosterone
US5660835A (en) * 1995-02-24 1997-08-26 East Carolina University Method of treating adenosine depletion
FR2803519B1 (en) * 2000-01-12 2002-03-22 Assist Publ Hopitaux De Paris ORAL USE OF DEHYDROEPIANDROSTERONE, ITS PRECURSORS AND DERIVATIVES FOR IMPROVING THE PAPYRACE OF THE SKIN
CA2842175C (en) * 2011-07-19 2019-10-15 Herman Jan Tijmen Coelingh Bennink Tablet containing dehydroepiandrosterone (dhea)

Also Published As

Publication number Publication date
GB2240472A (en) 1991-08-07
IE900306A1 (en) 1991-07-31
GB9101774D0 (en) 1991-03-13

Similar Documents

Publication Publication Date Title
GR3023762T3 (en) Cement composition.
ZA949221B (en) Titanium dioxide slurries.
EP0654252A3 (en) Dental prophylaxis and water conservation device.
EP0614944A3 (en) Intumescent composition of the two-components-type.
EP0571390A4 (en) The delay, prevention and/or reversal of cell senescence
HK58595A (en) Shampoo composition.
EP0738144A4 (en) Phenylmethyl hexanamides, and the use thereof
EP0664115A3 (en) Shampoo composition.
EP0706396A4 (en) 1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes and use
ZA923592B (en) Glass composition and use.
ZA91614B (en) Agent for use in the prevention,control or reversal of hypertension
GB9102796D0 (en) Water treatment agent
EP0369035A4 (en) Agent for treating pancreatitis or the like
EP0459660A3 (en) Halopropargyl compounds and the use thereof as microbicides
EP0592941A3 (en) Polyamide composition and the use.
ZA933815B (en) Pyrimidinyl- and triazinyl-salicyl- and -picolyl- amides and the use and preparation thereof.
EP0594211A3 (en) Aqueous organosiloxane liquid composition and its use.
GB9503413D0 (en) Sesquitterpenes,their preparation and their use as inhibitors acting on the gababenzodiazepine receptor
EP0490508A3 (en) Corrosion inhibitor, preparation and use
ZA931109B (en) Tetrahydropyrimidine derivatives.
ZA928765B (en) Novel 3-halo-5-halomethyl-2-oxazolidinones and their use as microbicides.
EP0625305A3 (en) Biocidal compositions and use thereof.
ZA932458B (en) Naphtoquinones and their use.
Hare The" Apotheosis of protestantism": the concept of work in Carlyle.
ZA927100B (en) The use of L-carnitine in endangered pregnacy.